EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy

Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma

(2012) C. A. Del Vecchio et al.   CANCER RESEARCH

Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation

(2012) S. Huang et al.   CANCER RESEARCH

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

(2012) S. Wheeler et al.   CLINICAL CANCER RESEARCH

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides

(2012) P. Filipazzi et al.   CLINICAL CANCER RESEARCH

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

(2012) L. P. Stabile et al.   CLINICAL CANCER RESEARCH

EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells

(2011) Lene Melsæther Grøvdal et al.   CELLULAR SIGNALLING

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a NovelIn VivoModel of Acquired Cetuximab Resistance

(2011) Kelly M. Quesnelle et al.   CLINICAL CANCER RESEARCH

Epidermal Growth Factor Receptor Inhibition Augments the Expression of MHC Class I and II Genes

(2011) B. P. Pollack et al.   CLINICAL CANCER RESEARCH

Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis

(2011) Katayama   INTERNATIONAL JOURNAL OF ONCOLOGY

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer

(2011) Satoshi Hayashi et al.   Journal of Translational Medicine

Toll-like receptor 3-mediated tumor invasion in head and neck cancer

(2011) Hui-Ching Chuang et al.   ORAL ONCOLOGY

Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer

(2010) K. Suda et al.   CLINICAL CANCER RESEARCH

HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers

(2009) Michael D. Walsh et al.   INTERNATIONAL JOURNAL OF CANCER

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

(2009) Stefan Michiels et al.   LANCET ONCOLOGY

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

(2008) Simona Vertuani et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Peptide epitope identification for tumor-reactive CD4 T cells

(2008) Hiroya Kobayashi et al.   CURRENT OPINION IN IMMUNOLOGY